Prognostic significance of arterial and venous thrombosis in resected specimens for non-small cell lung cancer

Thrombosis Research

Volumn 136, Issue 2, 2015, Pages 451-455

  Chen, Whenhui ^a   Zhang, Yuhui ^a   Yang, Yuanhua ^a   Zhai, Zhenguo ^a   Wang, Chen ^b  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

lung neoplasias; prognosis; thrombosis

Indexed keywords

EOSIN; HEMATOXYLIN;

ADULT; ARTERY THROMBOSIS; ARTICLE; CANCER GRADING; CANCER PATIENT; CANCER PROGNOSIS; CANCER SURGERY; CANCER SURVIVAL; CANCER TISSUE; CLINICAL FEATURE; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; LUNG RESECTION; MAJOR CLINICAL STUDY; MALE; NON SMALL CELL LUNG CANCER; OUTCOME ASSESSMENT; PREDICTIVE VALUE; PRIORITY JOURNAL; PULMONARY ARTERY; PULMONARY VEIN; STAINING; SURVIVAL RATE; TUMOR EMBOLISM; TUMOR VASCULARIZATION; VEIN THROMBOSIS; CARCINOMA, NON-SMALL-CELL LUNG; CHINA; COMORBIDITY; EPIDEMIOLOGY; INCIDENCE; LUNG NEOPLASMS; MIDDLE AGED; MORTALITY; PATHOLOGY; PROGNOSIS; PULMONARY EMBOLISM; REPRODUCIBILITY; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; TUMOR INVASION;

CARCINOMA, NON-SMALL-CELL LUNG; CHINA; COMORBIDITY; FEMALE; HUMANS; INCIDENCE; LUNG NEOPLASMS; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASTIC CELLS, CIRCULATING; PNEUMONECTOMY; PROGNOSIS; PULMONARY ARTERY; PULMONARY EMBOLISM; PULMONARY VEINS; REPRODUCIBILITY OF RESULTS; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; SURVIVAL RATE;

EID: 84938547143     PISSN: 00493848     EISSN: 18792472     Source Type: Journal    
DOI: 10.1016/j.thromres.2015.06.014     Document Type: Article

References (33)

1. J.A. Heit The epidemiology of venous thromboembolism in the community: implications for prevention and management J. Thromb. Thrombolysis 21 2006 23 29
2. I.A. Naess, S.C. Christiansen, P. Romundstad, S.C. Cannegieter, F.R. Rosendaal, and J. Hammerstrom Incidence and mortality of venous thrombosis: A population-based study J. Thromb. Haemost. 692-699 2007
3. F. Dentali, A. Malato, W. Ageno, A. Imperatori, M. Cajozzo, N. Rotolo, J. Douketis, S. Siragusa, and M. Crowther Incidence of venous thromboembolism in patients undergoing thoracotomy for lung cancer J. Thorac. Cardiovasc. Surg. 135 2008 705 706
4. G. Daddi, G. Milillo, L. Lupattelli, M. Ragusa, A. Lemmi, F. Puma, and G. Agnelli Postoperative pulmonary embolism detected with multislice computed tomography in lung surgery for cancer J. Thorac. Cardiovasc. Surg. 132 2006 197 198
5. D.P. Mason, M.A. Quader, E.H. Blackstone, J. Rajeswaran, M.M. DeCamp, S.C. Murthy, A.K. Quader, and T.W. Rice Thromboembolism after pneumonectomy for malignancy: an independent marker of poor outcome J. Thorac. Cardiovasc. Surg. 131 2006 711 718
6. A.Y. Lee, and M.N. Levine Venous thromboembolism and cancer: risks and outcomes Circulation 107 2003 I17 I21
7. G. Agnelli Prevention of venous thromboembolism in surgical patients Circulation 110 2004 IV4 IV12
8. J. Beyer-Westendorf, K. Halbritter, H. Platzbecker, U. Damme, B. Neugebauer, E. Kuhlisch, and S. Schellong Central adjudication of venous ultrasound in VTE screening trials: reasons for failure J. Thromb. Haemost. 9 3 2011 457 463
9. C.A. Wagenvoort Lung biopsy specimens in the evaluation of pulmonary vascular disease Chest 77 1980 614 625
10. C. Wang, M. Du, D. Cao, X. Weng, X. Wu, Q. Chang, and Y. Wang A pathological study of in situ thrombosis of small pulmonary arteries and arterioles in autopsy cases of chronic cor pulmonale Chin. Med. J. (Engl.) 111 1998 771 774
11. C.A. Wagenvoort Open lung biopsies in congenital heart disease for evaluation of pulmonary vascular disease. Predictive value with regard to corrective operability Histopathology 9 1985 417 436
12. Y.H. Zhang, C. Wang, L.M. Zhang, Z.G. Zhai, and B.S. Pang Effect of VEGF antisense oligonuleotides combined with low molecular weight heparin on tumor growth and pulmonary thromembolism in mice Lewis lung cancer J. Cap. Univ. Med. Sci. 27 2006 38 42
13. M.C. Kleinegris, A.J. Ten Cate-Hoek, and H. Ten Cate Coagulation and the vessel wall in thrombosis and atherosclerosis Pol. Arch. Med. Wewn. 122 2012 557 566
14. A.S. Wolberg, M.M. Aleman, K. Leiderman, and K.R. Machlus Procoagulant activity in hemostasis and thrombosis: Virchow's triad revisited Anesth. Analg. 114 2012 275 285
15. T.A. Morris Natural history of venous thromboembolism Crit. Care Clin. 27 2011 869 884
16. C. Gerges, M. Gerges, M.B. Lang, Y. Zhang, J. Jakowitsch, P. Probst, G. Maurer, and I.M. Lang Diastolic pulmonary vascular pressure gradient: a predictor of prognosis in «out-of-proportion» pulmonary hypertension Chest 143 3 2013 758 766
17. I.E. Hall, M.S. Andersen, H.M. Krumholz, and C.P. Gross Predictors of venous thromboembolism in patients with advanced common solid cancers J. Cancer Epidemiol. 2009 2009 182521
18. M. Ogren, D. Bergqvist, K. Wahlander, H. Eriksson, and N.H. Sternby Trousseau's syndrome - what is the evidence? A population-based autopsy study Thromb. Haemost. 95 2006 541 545
19. H.K. Chew, A.M. Davies, T. Wun, D. Harvey, H. Zhou, and R.H. White The incidence of venous thromboembolism among patients with primary lung cancer J. Thromb. Haemost. 6 2008 601 608
20. J.W. Blom, S. Osanto, and F.R. Rosendaal The risk of a venous thrombotic event in lung cancer patients: higher risk for adenocarcinoma than squamous cell carcinoma J. Thromb. Haemost. 2 2004 1760 1765
21. M.E. Tesselaar, and S. Osanto Risk of venous thromboembolism in lung cancer Curr. Opin. Pulm. Med. 13 2007 362 367
22. J. Ahlbrecht, B. Dickmann, C. Ay, D. Dunkler, J. Thaler, M. Schmidinger, P. Quehenberger, A. Haitel, C. Zielinski, and I. Pabinger Tumor grade is associated with venous thromboembolism in patients with cancer: results from the vienna cancer and thrombosis study J. Clin. Oncol. 30 2012 3870 3875
23. A.K. Kakkar, and F. Macbeth Antithrombotic therapy and survival in patients with malignant disease Br. J. Cancer 102 Suppl. 1 2010 S24 S29
24. G. Kalweit, H. Huwer, I. Volkmer, T. Petzold, and E. Gams Pulmonary embolism: a frequent cause of acute fatality after lung resection Eur. J. Cardiothorac. Surg. 10 1996 242 246 (discussion 246-7)
25. R. Kanz, T. Vukovich, R. Vormittag, D. Dunkler, C. Ay, J. Thaler, J. Haselbock, W. Scheithauer, C. Zielinski, and I. Pabinger Thrombosis risk and survival in cancer patients with elevated C-reactive protein J. Thromb. Haemost. 9 2011 57 63
26. J. Rak, C. Milsom, L. May, P. Klement, and J. Yu Tissue factor in cancer and angiogenesis: the molecular link between genetic tumor progression, tumor neovascularization, and cancer coagulopathy Semin. Thromb. Hemost. 32 2006 54 70
27. P. Zania, M. Papaconstantinou, C.S. Flordellis, M.E. Maragoudakis, and N.E. Tsopanoglou Thrombin mediates mitogenesis and survival of human endothelial cells through distinct mechanisms Am. J. Physiol. Cell Physiol. 294 2008 C1215 C1226
28. W. Ruf, J. Disse, T.C. Carneiro-Lobo, N. Yokota, and F. Schaffner Tissue factor and cell signalling in cancer progression and thrombosis J. Thromb. Haemost. 9 Suppl. 1 2011 306 315
29. A.J.C. Philip, S. Rajesh, S. Yvonne, D. Caroline, and B. Fiona Prognostic and predictive biomarkers in early stage NSCLC: CTCs and serum/plasma markers.Transl Lung Cancer Res. 2 5 2013 382 397
30. X.L. Ma, Z.L. Xiao, L. Liu, X.X. Liu, W. Nie, P. Li, N.Y. Chen, and Y.Q. Wei Meta-analysis of circulating tumor cells as a prognostic marker in lung cancer Asian Pac. J. Cancer Prev. 13 2012 1137 1144
31. R.M. Bremnes, R. Sirera, and C. Camps Circulating tumourderived DNA and RNA markers in blood: a tool for early detection, diagnostics, and follow-up? Lung Cancer 49 2005 1 12
32. T. Muley, H. Dienemann, and W. Ebert CYFRA 21-1 and CEA are independent prognostic factors in 153 operated stage I NSCLC patients Anticancer Res. 24 2004 1953 1956
33. M. Tomita, T. Shimizu, T. Ayabe, and et al. Prognostic significance of tumour marker index based on preoperative CEA and CYFRA 21-1 in non-small cell lung cancer Anticancer Res. 30 2010 3099 3102